OLABISI OLUSEUN AGBAJE
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family GRANBURY, TX NPI 1730698317
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family TX Acerta Pharma LLC All categories
General Payments — all program years on this page
$994.46
- Category: General Payments
- Program years: PY2022–2024
- Record count: 41
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $318.30 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $318.30 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $274.82 | 4 |
| ABBVIE INC. | $15.97 | 1 |
| ITI, Inc. | $14.42 | 1 |
| Otsuka America Pharmaceutical, Inc. | $13.09 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1104203829 | AstraZeneca Pharmaceuticals LP | $121.75 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104251915 | AstraZeneca Pharmaceuticals LP | $114.75 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104271149 | AstraZeneca Pharmaceuticals LP | $16.12 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105675079 | AstraZeneca Pharmaceuticals LP | $22.20 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1106416287 | ABBVIE INC. | $15.97 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1119012025 | Otsuka America Pharmaceutical, Inc. | $13.09 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143353927 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $14.42 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.